Lupkynis Uniunea Europeană - română - EMA (European Medicines Agency)

lupkynis

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - imunosupresoare - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).

LUPKYNIS 7,9 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lupkynis 7,9 mg

millmount healthcare limited - irlanda - voclosporinum - caps. moi - 7,9mg - imunosupresoare inhibitori de calcineurina